Top Markets
Coin of the day
BNC Korea Co., Ltd. BNC Korea Co., Ltd.

BNC Korea Co., Ltd.

256840
株式のランク #21183
Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development,... Based in South Korea, BNC Korea Co., Ltd. focuses on the research, development, manufacturing, and distribution of various biomaterials. The company's diverse product range features hyaluronic acid (HA) and skin booster fillers, including brand names like Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, all designed for the temporary reduction of facial wrinkles through physical restoration. Beyond aesthetic products, BNC Korea also manufactures Hibarry, a specialized dressing for deep-cavity wounds, which helps mitigate spinal cord adhesion during surgery. Another key medical product is GENTA Q, a white collagen sponge created to protect wounds by preventing contamination. Additionally, the company offers a line of beauty solutions, encompassing face mask gels, mild cleansing foams, and brightening peeling gels. With a significant international presence, BNC Korea exports its products to 45 countries. The firm was founded in 2007 and is headquartered in Daegu, South Korea.
株価
$1.65
最終同期: 2026-08-21
時価総額
$113.03M
変化(1日)
-3.63%
変化(1年)
-52.19%
KR
取引 BNC Korea Co., Ltd. (256840)

カテゴリー

BNC Korea Co., Ltd.(256840)の収益
Aug 2026 時点の収益 TTM: 0
BNC Korea Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
BNC Korea Co., Ltd. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。